FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to novel cyanoguanidines of the formula (I) where joining to pyridine ring is performed at 3 or 4 position; R means one or more substitutes that are taken among group comprising of hydrogen atom, C1-C4-alkyl or alkoxy-group; Q means linear saturated bivalent hydrocarbon C5-C14-radical; X means carboxy-, amino-, tetrahydropyranyl-hydroxy-group, C1-C4-saturated or unsaturated alkoxycarbonylamino-, alkoxycarbonyl- or di-(alkoxy)- phosphinoylhydroxy-group. Compounds of the formula (I) inhibit undesirable cell proliferation and can be used in medicine. EFFECT: improved method of synthesis, valuable medicinal properties. 8 cl, 2 tbl, 22 ex _
Authors
Dates
2002-12-20—Published
1998-05-15—Filed